羊水干細胞在再生醫學的研究進展_《中國修復重建外科雜志》

作者：

李春 ¹ , 李巍松 ¹ , 劉虎 ¹ , 汪潔 ²

1安徽醫科大學第一附屬醫院小兒外科（合肥，230022）;;
2安徽醫科大學第四附屬醫院皮膚科;

關鍵詞：

羊水干細胞多向分化再生醫學組織工程

DOI：

10.7507/1002-1892.20130275

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的對羊水干細胞（amniotic fluid-derived stem cells，AFSCs）的研究進展及在再生醫學等領域的發展進行綜述，探討今后AFSCs研究的相關問題。方法查閱近年來AFSCs的相關文獻，對AFSCs在再生醫學領域研究的成果及其基礎與臨床研究展望進行綜述。結果目前研究已表明AFSCs具有多向分化潛能，在組織工程或細胞替代治療的研究中展現出廣闊的應用前景。結論羊水取材簡便，對母嬰創傷小，無致瘤性，無倫理學方面的限制，使AFSCs極有希望成為再生醫學、抗腫瘤等領域中理想的種子細胞，具有廣泛研究價值。

引用本文： 李春,李巍松,劉虎,汪潔. 羊水干細胞在再生醫學的研究進展. 中國修復重建外科雜志, 2013, 27(10): 1262-1266. doi: 10.7507/1002-1892.20130275 復制

1.	Torricelli F, Brizzi L, Bernabei PA, et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol, 1993, 98(2): 119-126.
2.	Rosner M, Schipany K, Shanmugasundaram B, et al. Amniotic fluid stem cells: future perspectives. Stem Cells, 2012, 2012: 741810.
3.	Gundacker C, Dolznig H, Mikula M, et al. Amniotic fluid stem cell-based models to study the effects of genemutations and toxicants onmale germ cell formation. Asian J Androl, 2012, 14(2): 247-250.
4.	Rosner M, Dolznig H, Schipany K, et al. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget, 2011, 2(9): 705-712.
5.	Rosner M, Schipany K, Gundacker C, et al. Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases. Euro J Clin Invest, 2012, 42(6): 677-684.
6.	Da Sacco S, Sedrakyan S, Boldrin F, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol, 2010, 183(3): 1193-1200.
7.	Kang NH, Hwang KA, Kim YB, et al. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells. Cancer Gene Ther, 2012, 19(8): 517-522.
8.	Cabral AC, Angelo PC, Leite HV, et al. Isolation differentiation and biochemical aspects of amniotic fluid stem cell. Rev Assoc Med Bras, 2008, 54(6): 489-493.
9.	Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med, 2007, 1(4) : 296-305.
10.	Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet, 2006, 367(9518): 1241-1246 .
11.	Raya-Rivera A, Esquiliano DR, Yoo JJ, et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet, 2011, 377(9772): 1175-1182.
12.	Yang DY, Sheu ML, Su HL, et al. Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1α in a sciatic nerve injury model. J Neurosurg, 2012, 116(6): 1357-1367.
13.	Joo S, Kol K, Atala A, et al. Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res, 2012, 35(2): 271-280.
14.	Prasongchean W, Bagni M, Calzarossa C, et al. Amniotic fluid stem cells increase embryo survival following injury. Stem Cells, 2012, 21(5): 675-688.
15.	De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol, 2007, 177(1): 369-376.
16.	Lee WY, Wei HJ, Lin WW, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stemcell bodies enriched with endogenous ECM. Biomaterials, 2011, 32(24): 5558-5567.
17.	Mirabella T, Cilli M, Carlone S, et al. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials, 2011, 32(15): 3689-3699.
18.	Carraro G, Perin L, Sedrakyan S, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells, 2008, 26(11): 2902-2911.
19.	Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther, 2009, 17(5): 758-766.
20.	Bollini S, Pozzobon M, Nobles M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev, 2011, 7(2): 364-380.
21.	Yeh YC, Wei HJ, Lee WY, et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A, 2010, 16(6): 1925-1936.
22.	Weber B, Zeisberger SM, Hoerstrup SP. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta, 2011, 32 Suppl 4: S316-S319.
23.	Schmidt D, Achermann J, Odermatt B, et al. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis, 2008, 17(4): 446-455.
24.	Parolini O, Soncini M, Evangelista M, et al. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med, 2009, 4(2): 275-291.
25.	Fauza DO, Marler JJ, Koka R, et al. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg , 2001, 36(1): 146-151.
26.	Zheng YB, Zhang XH, Huang ZL, et al. Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One, 2012, 7(7): e41392.
27.	Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif, 2007, 40(6): 936-948.
28.	Sedrakyan S, Da Sacco S, Milanesi A, et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol, 2012, 23(4): 661-673.
29.	Perin L, Sedrakyan S, Giuliani S, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One, 2010, 5(2): e9357.
30.	Sun H, Feng K, Hu J, et al. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials, 2010, 31(6): 1133-1139.
31.	De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 2007, 25(1): 100-106.
32.	Peister A, Deutsch ER, Kolambkar Y, et al. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A, 2009, 15(10): 3129-3138.
33.	Dupont KM, Boerckel JD, Stevens HY, et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res, 2012, 347(3): 575-588.
34.	Turner CG, Klein JD, Gray FL, et al. Craniofacial repair with fetal bone grafts engineered from amniotic mesenchymal stem cells. J Surg Res, 2012, 178(2): 785-790.
35.	Kolambkar YM, Peister A, Soker S, et al. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol, 2007, 38(5): 405-413.
36.	Iacono E, Merlo B, Pirrone A, et al. Effects of mesenchymal stem cells isolated from amniotic fluid and platelet-rich plasma gel on severe decubitus ulcers in a septic neonatal foal. Res Vet Sci, 2012, 93(3): 1439-1440.
37.	Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature, 2010, 467(7313): 285-290.
38.	Fuchs C, Rosner M, Dolznig H, et al. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem cell differentiation. Hum Mol Genet, 2012, 21(5): 1049-1061.
39.	Phermthai T, Odglun Y, Julavijitphong S, et al. A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol, 2010, 11: 79.
40.	Bitsika V, Roubelakis MG, Zagoura D, et al. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev, 2012, 21(7): 1097-1111.
41.	Kang NH, Hwang KA, Yi BR, et al. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models. Cancer Gene Ther, 2012, 19(6): 412-419.
42.	Rosner M, Siegel N, Fuchs C, et al. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nature Protocols, 2010, 5(6): 1081-1095.
43.	Manuelpillai U, Moodley Y, Borlongan CV, et al. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta, 2011, 32 Suppl 4: S320-S325.
44.	羅宏武, 黃湘俊, 黃飛舟, 等. 人羊膜上皮細胞橫向分化及脾內移植的初步研究. 中國修復重建外科雜志, 2011, 25(2): 144-148.
45.	涂長玉, 程敏, 李華鋒, 等. 羊水穿刺超聲定位的有關問題探討. 中國優生優育, 2009, 15(1): 25-26.

1. Torricelli F, Brizzi L, Bernabei PA, et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol, 1993, 98(2): 119-126.
2. Rosner M, Schipany K, Shanmugasundaram B, et al. Amniotic fluid stem cells: future perspectives. Stem Cells, 2012, 2012: 741810.
3. Gundacker C, Dolznig H, Mikula M, et al. Amniotic fluid stem cell-based models to study the effects of genemutations and toxicants onmale germ cell formation. Asian J Androl, 2012, 14(2): 247-250.
4. Rosner M, Dolznig H, Schipany K, et al. Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis. Oncotarget, 2011, 2(9): 705-712.
5. Rosner M, Schipany K, Gundacker C, et al. Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases. Euro J Clin Invest, 2012, 42(6): 677-684.
6. Da Sacco S, Sedrakyan S, Boldrin F, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol, 2010, 183(3): 1193-1200.
7. Kang NH, Hwang KA, Kim YB, et al. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells. Cancer Gene Ther, 2012, 19(8): 517-522.
8. Cabral AC, Angelo PC, Leite HV, et al. Isolation differentiation and biochemical aspects of amniotic fluid stem cell. Rev Assoc Med Bras, 2008, 54(6): 489-493.
9. Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med, 2007, 1(4) : 296-305.
10. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet, 2006, 367(9518): 1241-1246 .
11. Raya-Rivera A, Esquiliano DR, Yoo JJ, et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet, 2011, 377(9772): 1175-1182.
12. Yang DY, Sheu ML, Su HL, et al. Dual regeneration of muscle and nerve by intravenous administration of human amniotic fluid-derived mesenchymal stem cells regulated by stromal cell-derived factor-1α in a sciatic nerve injury model. J Neurosurg, 2012, 116(6): 1357-1367.
13. Joo S, Kol K, Atala A, et al. Amniotic fluid-derived stem cells in regenerative medicine research. Arch Pharm Res, 2012, 35(2): 271-280.
14. Prasongchean W, Bagni M, Calzarossa C, et al. Amniotic fluid stem cells increase embryo survival following injury. Stem Cells, 2012, 21(5): 675-688.
15. De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol, 2007, 177(1): 369-376.
16. Lee WY, Wei HJ, Lin WW, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stemcell bodies enriched with endogenous ECM. Biomaterials, 2011, 32(24): 5558-5567.
17. Mirabella T, Cilli M, Carlone S, et al. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials, 2011, 32(15): 3689-3699.
18. Carraro G, Perin L, Sedrakyan S, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells, 2008, 26(11): 2902-2911.
19. Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther, 2009, 17(5): 758-766.
20. Bollini S, Pozzobon M, Nobles M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev, 2011, 7(2): 364-380.
21. Yeh YC, Wei HJ, Lee WY, et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A, 2010, 16(6): 1925-1936.
22. Weber B, Zeisberger SM, Hoerstrup SP. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta, 2011, 32 Suppl 4: S316-S319.
23. Schmidt D, Achermann J, Odermatt B, et al. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis, 2008, 17(4): 446-455.
24. Parolini O, Soncini M, Evangelista M, et al. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med, 2009, 4(2): 275-291.
25. Fauza DO, Marler JJ, Koka R, et al. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg , 2001, 36(1): 146-151.
26. Zheng YB, Zhang XH, Huang ZL, et al. Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One, 2012, 7(7): e41392.
27. Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif, 2007, 40(6): 936-948.
28. Sedrakyan S, Da Sacco S, Milanesi A, et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol, 2012, 23(4): 661-673.
29. Perin L, Sedrakyan S, Giuliani S, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One, 2010, 5(2): e9357.
30. Sun H, Feng K, Hu J, et al. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials, 2010, 31(6): 1133-1139.
31. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 2007, 25(1): 100-106.
32. Peister A, Deutsch ER, Kolambkar Y, et al. Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A, 2009, 15(10): 3129-3138.
33. Dupont KM, Boerckel JD, Stevens HY, et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res, 2012, 347(3): 575-588.
34. Turner CG, Klein JD, Gray FL, et al. Craniofacial repair with fetal bone grafts engineered from amniotic mesenchymal stem cells. J Surg Res, 2012, 178(2): 785-790.
35. Kolambkar YM, Peister A, Soker S, et al. Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol, 2007, 38(5): 405-413.
36. Iacono E, Merlo B, Pirrone A, et al. Effects of mesenchymal stem cells isolated from amniotic fluid and platelet-rich plasma gel on severe decubitus ulcers in a septic neonatal foal. Res Vet Sci, 2012, 93(3): 1439-1440.
37. Kim K, Doi A, Wen B, et al. Epigenetic memory in induced pluripotent stem cells. Nature, 2010, 467(7313): 285-290.
38. Fuchs C, Rosner M, Dolznig H, et al. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem cell differentiation. Hum Mol Genet, 2012, 21(5): 1049-1061.
39. Phermthai T, Odglun Y, Julavijitphong S, et al. A novel method to derive amniotic fluid stem cells for therapeutic purposes. BMC Cell Biol, 2010, 11: 79.
40. Bitsika V, Roubelakis MG, Zagoura D, et al. Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. Stem Cells Dev, 2012, 21(7): 1097-1111.
41. Kang NH, Hwang KA, Yi BR, et al. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models. Cancer Gene Ther, 2012, 19(6): 412-419.
42. Rosner M, Siegel N, Fuchs C, et al. Efficient siRNA-mediated prolonged gene silencing in human amniotic fluid stem cells. Nature Protocols, 2010, 5(6): 1081-1095.
43. Manuelpillai U, Moodley Y, Borlongan CV, et al. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta, 2011, 32 Suppl 4: S320-S325.
44. 羅宏武, 黃湘俊, 黃飛舟, 等. 人羊膜上皮細胞橫向分化及脾內移植的初步研究. 中國修復重建外科雜志, 2011, 25(2): 144-148.
45. 涂長玉, 程敏, 李華鋒, 等. 羊水穿刺超聲定位的有關問題探討. 中國優生優育, 2009, 15(1): 25-26.

上一篇
血紅素氧化酶1在骨組織工程中的應用分析研究進展
下一篇
椎弓根釘骨水泥強化技術應用進展

《中國修復重建外科雜志》

羊水干細胞在再生醫學的研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

《中國修復重建外科雜志》

羊水干細胞在再生醫學的研究進展

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料